UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K/A

(Amendment No. 1)

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2025

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT 1934

 

Commission File Number: 001-41371

 

EDIBLE GARDEN AG INCORPORATED

(Exact name of registrant as specified in its charter)

 

Delaware

 

85-0558704

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

283 County Road 519

Belvidere, NJ 07823

(Address of principal executive offices) (Zip Code)

 

(908) 750-3953

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

EDBL

The Nasdaq Stock Market LLC

Warrants to purchase Common Stock

EDBLW

The Nasdaq Stock Market LLC

 

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes ☐    No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act.  Yes ☐    No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒    No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes ☒    No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer,  a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes      No ☒ 

 

The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold on June 30, 2025 (the last business day of the registrant’s most recently completed second fiscal quarter), was approximately $7.7 million.

 

As of April 27, 2026, the registrant had 5,213,691 shares of Common Stock, $0.0001 par value per share, outstanding.

 

 

 

 

EXPLANATORY NOTE

 

On March 31, 2026, Edible Garden AG Incorporated (“Edible Garden,” the “Company,” “we,” “us,” or “our”) filed our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “Original Form 10-K”). The Original Form 10-K omitted Part III, Items 10 (Directors, Executive Officers and Corporate Governance), 11 (Executive Compensation), 12 (Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters), 13 (Certain Relationships and Related Transactions, and Director Independence) and 14 (Principal Accountant Fees and Services) in reliance on General Instruction G(3) to Form 10-K, which provides that such information may be either incorporated by reference from the registrant’s definitive proxy statement or included in an amendment to Form 10-K, in either case filed with the Securities and Exchange Commission (the “SEC”) not later than 120 days after the end of the fiscal year.

 

The Board of Directors has not yet established the date of the 2026 annual meeting of shareholders. When the date is established, the Company will announce it in its filings made with the SEC. Consequently, our definitive proxy statement for the 2026 annual meeting of shareholders will be filed later than the 120th day after the end of the last fiscal year. Accordingly, this Amendment No. 1 to Form 10-K (this “Amendment”) is being filed solely to:

 

 

·

amend Part III, Items 10, 11, 12, 13 and 14 of the Original Form 10-K to include the information required by such Items;

 

 

 

 

·

delete the reference on the cover of the Original Form 10-K to the incorporation by reference of portions of our proxy statement into Part III of the Original Form 10-K; and

 

 

 

 

·

file new certifications of our principal executive officer and principal financial officer as exhibits to this Amendment under Item 15 of Part IV hereof, pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

 

This Amendment does not otherwise change or update any of the disclosures set forth in the Original Form 10-K and does not otherwise reflect any events occurring after the filing of the Original Form 10-K.

 

i

 

 

EDIBLE GARDEN AG INCORPORATED

AMENDMENT NO. 1 TO ANNUAL REPORT ON FORM 10-K/A

TABLE OF CONTENTS

 

PART III

 

Page

 

Item 10. Directors, Executive Officers and Corporate Governance

 

 

2

 

Item 11. Executive Compensation

 

 

5

 

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 

 

8

 

Item 13. Certain Relationships and Related Transactions and Director Independence

 

 

10

 

Item 14. Principal Accountant Fees and Services

 

 

12

 

PART IV

 

 

 

 

Item 15. Exhibits and Financial Statement Schedules

 

 

13

 

SIGNATURES

 

 

19

 

 
1

Table of Contents

 

PART III

 

Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

The following table sets forth certain information regarding our directors and executive officers as of March 31, 2026: 

 

Name

 

Age

 

Position

James E. Kras

 

57

 

Chief Executive Officer, President, Treasurer, Secretary and Director

Kostas Dafoulas

 

46

 

Interim Chief Financial Officer

Pamela DonAroma

 

70

 

Director

Mathew McConnell

 

67

 

Executive Vice President, Director

Michael Naidrich

 

55

 

Director

Ryan Rogers

 

44

 

Director

James E. Kras. Mr. Kras is one of our founders and has served as Chief Executive Officer and a director since our inception in March 2020. Mr. Kras served as President and Chief Marketing Officer of Edible Garden Corp., a wholly-owned subsidiary of Unrivaled Brands (formerly Terra Tech), from March 2016 to March 2020. Prior to that service, Mr. Kras held senior leadership positions in marketing at global leaders Ajinomoto, a multinational food and biotechnology corporation, and The Bountiful Company (formerly The Nature’s Bounty Company), a producer of dietary supplements. Mr. Kras started his career on Madison Avenue in advertising with various global advertising and marketing companies including Grey Advertising and Carat Interactive a subsidiary of Dentsu International. Mr. Kras is the nephew of Pamela DonAroma, one of our directors. As our Chief Executive Officer and one of our founders, Mr. Kras brings to the Board extensive knowledge of our products, structure, and culture as well as years of expertise in the industry.

 

Kostas DafoulasMr. Dafoulas has served as our interim Chief Financial Officer since January 2024. He previously served as a consultant to us on behalf of CapConnect+, Inc. (“CapConnect”) to provide financial reporting and related services. Mr. Dafoulas also serves as Head of Advisory & Finance at CapConnect, where he has served since September 2021. Mr. Dafoulas previously served as Treasurer at Semrush, Inc. from April 2020 to September 2021. From December 2017 to April 2020, Mr. Dafoulas was Director of Treasury at Circle Internet Financial, as well as Head of Finance for Poloniex, a subsidiary of Circle.

 

Pamela DonAroma. Ms. DonAroma has served as one of our directors since April 2023 and as Chief Executive Officer and President of Futures Inc. since its inception in 1989. Futures Inc. is a non-profit organization that advocates for individuals with disabilities through professional development, community-based education and employment opportunities. In her position at Futures Inc., Ms. DonAroma is responsible for all aspects of agency communication, development, human resource management, governmental compliance, accreditation, and financial operations. Ms. DonAroma is the aunt of James Kras, our Chief Executive Officer. Ms. DonAroma was chosen to serve as a director because of her extensive leadership experience and experience in building out an organization and serving on government-appointed boards in Connecticut, as well as her certification as a Master Gardener, which we believe will be important as we ramp up our organizational buildout.

 

Mathew McConnell. Mr. McConnell has served as one of our directors since May 2022 and our Executive Vice President since December 2025. Mr. McConnell served as Head of US Equity Capital Markets at BancTrust & Co. Investment Bank, an investment bank, from April 2024 to November 2025. Prior to this, Mr. McConnell served as a part-time consultant at CapConnect from July 2023 to April 2024. Mr. McConnell previously served as Chief Executive Officer of Marco Polo Securities, Inc.’s MPS Chaperone and Distribution business from February 2020 to September 2022. In this position, he oversaw international equities, trading, and capital markets processes for this U.S. broker-dealer offering cross-border regulatory and distribution solutions to a robust network of local securities firms across the world. From 2018 to 2020, Mr. McConnell served as Managing Director, Head of Equity Capital Markets of Tellimer (Exotix Capital), a financial brokerage firm, including as a member of its U.S. executive committee. Prior to Tellimer, Mr. McConnell was Head of Capital Markets at Auerbach Grayson, a financial brokerage firm, from 2014 to 2018. Mr. McConnell was chosen to serve as a director because of his extensive international financial and capital markets experience, which we believe will be important as we implement our growth strategy.

 

 
2

Table of Contents

 

Michael Naidrich. Mr. Naidrich has served as one of our directors since December 2025. Mr. Naidrich has served as co-Chief Executive Officer of AmeriVet Securities, Inc., a service-disabled veteran-owned business and Minority Business Enterprise providing capital markets and financing services across multiple lines of business, since December 2020. From March 2016 to January 2021, he led the Capital Markets team at Tigress Financial Partners, where he advised public companies on market strategy, capital formation, and investor engagement. Prior to his service at Tigress Financial Partners, Mr. Naidrich served as President of Nova Capital Markets, overseeing the firm’s day-to-day operations, regulatory compliance, and strategic execution. Earlier in his career, he played a leadership role in the development of a direct access trading platform at Moors & Cabot following the acquisition of NDB Capital Markets by Deutsche Bank. Prior to the acquisition, Mr. Naidrich held senior leadership and trading roles at NDB Capital Markets and served on the firm’s Senior Management team. Mr. Naidrich maintains multiple FINRA registrations. Mr. Naidrich was chosen to serve as a director because he brings more than three decades of experience in capital markets, financial services leadership, and public-company governance.

 

Ryan Rogers. Mr. Rogers has served as one of our directors since May 2022 and has spent nearly two decades working in the food retail industry in various merchandising, sales and sourcing positions. Mr. Rogers is the founder of Retail Optics, a consulting firm focused on navigating complex problems within the retail space and has served as president since February 2022. From June 2021 until February 2022, he served as client business manager and business development manager for FDM Sales, a brand development organization helping accelerate growth for food and beverage brands. Prior to joining FDM Sales, Mr. Rogers spent 18 years at Target Corp, a retail corporation, where he held merchandising and sourcing roles of increasing responsibility within its food division, including produce buyer, where he led the growth strategy for packaged salads, vegetarian, and healthy snacking. Mr. Rogers was chosen to serve as a director because of his extensive experience in our industry and his ability to help organizations like ours accelerate growth.

 

Family Relationships

 

Except as noted in the biographies above, there are no family relationships between any director or executive officer.

 

CORPORATE GOVERNANCE

 

Our Board consists of James Kras, Pamela DonAroma, Mathew McConnell, Michael Naidrich and Ryan Rogers.

 

Board Committees

 

Our Board has established three standing committees: the audit committee, the compensation committee, and the nominating and governance committee. Each of these committees consist solely of independent directors. Our audit committee was established in accordance with Section 3(a)(58)(A) of the Exchange Act.

 

Audit Committee

 

The audit committee is responsible for, among other matters:

 

 

·

appointing, compensating, retaining, evaluating, terminating, and overseeing our independent registered public accounting firm;

 

·

discussing with our independent registered public accounting firm the independence of its members from its management;

 

·

reviewing with our independent registered public accounting firm the scope and results of their audit;

 

·

approving all audit and permissible non-audit services to be performed by our independent registered public accounting firm;

 

·

overseeing the financial reporting process and discussing with management and our independent registered public accounting firm the interim and annual financial statements that we file with the SEC;

 

·

reviewing and monitoring our accounting principles, accounting policies, financial and accounting controls, and compliance with legal and regulatory requirements;

 

·

coordinating the oversight by our Board of our code of ethics and our disclosure controls and procedures;

 

·

maintaining procedures for the confidential and/or anonymous submission of concerns regarding accounting, internal controls or auditing matters; and

 

·

reviewing and approving related-person transactions.
 
3

Table of Contents

 

Michael Naidrich, Pamela DonAroma, and Ryan Rogers serve on the audit committee and meet the definition of “independent director” for purposes of serving on an audit committee under Rule 10A-3 under the Exchange Act and Nasdaq rules. Mr. Naidrich serves as the Chair of the audit committee. Mr. Naidrich qualifies as an “audit committee financial expert,” as such term is defined in Item 407(d)(5) of Regulation S-K.

 

Compensation Committee

 

The compensation committee is responsible for, among other matters: 

 

 

·

reviewing key employee compensation goals, policies, plans and programs;

 

·

reviewing and approving the compensation of our directors and executive officers;

 

·

reviewing and approving employment agreements and other similar arrangements between us and our executive officers; and

 

·

appointing and overseeing any compensation consultants or advisors.

Ryan Rogers, Pamela DonAroma, and Michael Naidrich serve on the compensation committee and meet the definition of “independent director” for purposes of serving on a compensation committee under Nasdaq rules. Mr. Rogers serves as the Chair of the compensation committee.

 

Nominating and Governance Committee

 

The nominating and governance committee is responsible for assisting the Board in identifying qualified individuals to become directors, in determining the composition of the Board and in monitoring the process to assess Board effectiveness. Pamela DonAroma, Michael Naidrich, and Ryan Rogers serve on the nominating and governance committee and Ms. DonAroma is the Chair of the nominating and governance committee.

 

Risk Oversight

 

Our Board oversees a company-wide approach to risk management. Our Board will determine the appropriate risk level for us generally, assess the specific risks faced by us and review the steps taken by management to manage those risks. While our Board has ultimate oversight responsibility for the risk management process, its committees will oversee risk in certain specified areas.

 

Specifically, our compensation committee is responsible for overseeing the management of risks relating to our executive compensation plans and arrangements, and the incentives created by the compensation awards it administers. Our audit committee oversees management of enterprise risks and financial risks, as well as potential conflicts of interest. Our Board is responsible for overseeing the management of risks associated with the independence of our Board.

 

Code of Ethics

 

Our Board has adopted a Code of Ethics that applies to our directors, officers and employees. A copy of this code is available on our website at ediblegardenag.com/investors. We intend to disclose on our website any amendments to the Code of Ethics and any waivers of the Code of Ethics that apply to our principal executive officer, principal financial officer, principal accounting officer, controller, or persons performing similar functions.

 

 
4

Table of Contents

 

Insider Trading Policy 

 

We have adopted an insider trading policy designed to promote compliance with insider trading laws, rules and regulations, and any listing standards applicable to the Company. The policy applies to all employees, officers and directors of the Company. Key Employees (our directors, executive officers and certain employees who our compliance committee may designate from time to time), may only buy and sell our stock within an open “window period,” which begins 48 hours after the release of the Company’s quarterly or annual financial results and ends on the last day of the next fiscal quarter. Key Employees are prohibited from purchasing or selling our stock if they are in possession of material non-public information, even if it is within the open “window period.”

 

Director and Officer Indemnification Agreements

 

We are party to separate indemnification agreements with our directors and executive officers, in addition to the indemnification provided for in our certificate of incorporation and bylaws. These agreements, among other things, require us to indemnify our directors and executive officers for certain expenses, including attorneys’ fees, judgments, penalties, fines and settlement amounts incurred by a director or executive officer in any action or proceeding arising out of their services as one of our directors or executive officers or as a director or executive officer of any other company or enterprise to which the person provides services at our request. The indemnification agreements and our certificate of incorporation and bylaws require us to indemnify our directors and officers to the fullest extent permitted by Delaware law.

 

Item 11. EXECUTIVE COMPENSATION

 

Summary Compensation Table

 

The following table provides information regarding the compensation paid for the years ended December 31, 2025 and 2024 to each of the executive officers named below, who are collectively referred to as “named executive officers” elsewhere in this proxy statement.

 

Name and Principal Position

 

Year

 

Salary

($)

 

 

Bonus

($)

 

 

Stock Awards

($)

 

 

Option Awards ($)

 

 

All Other Compensation

($)

 

 

Total

($)

 

James E. Kras,

 

2025

 

 

409,615

 

 

 

500,000

(1) 

 

 

1,000,000

(2) 

 

 

1,000,000

(3) 

 

 

9,750

(4) 

 

 

2,919,365

 

Chief Executive Officer

 

2024

 

 

300,000

 

 

 

200,000

 

 

 

 

 

 

 

 

 

 

 

500,000

 

Kostas Dafoulas,

 

2025

 

 

240,000

 

 

 

 

 

 

 

 

 

 

 

 

 

240,000

 

Interim Chief Financial Officer

 

2024

 

 

213,100

 

 

 

 

 

 

 

 

 

 

 

 

 

213,100

 

Mathew McConnell Executive Vice President and Director(5)

 

2025

 

 

21,154

 

 

 

 

 

 

 

 

 

 

 

258,654

(6) 

 

 

279,808

 

 

(1)

Represents discretionary cash bonuses paid to Mr. Kras following the completion of the transactions between the Company, Edible Garden Sustainable Ventures LLC, our wholly owned subsidiary, NaturalShrimp Farms Inc. and Streeterville Capital, LLC.

(2)

Represents the grant date fair value computed in accordance with the requirements of accounting for stock-based compensation. The amounts reported in this column have been computed in accordance with the Financial Accounting Standards Board’s Accounting Standards Codification Topic 718.

(3)

The fair value for stock options granted during 2025 was estimated at the date of grant using the Black-Scholes option pricing model.

(4)

Represents Mr. Kras’s car allowance for use of his personal vehicle in connection with travel on behalf of the Company.

(5)

Mr. McConnell became Executive Vice President of the Company, effective December 1, 2025.

(6)

Represents $158,654 paid in cash and a restricted stock award valued at $100,000 under the 2025 Director and Officer Equity Incentive Plan (the “2025 Plan”) to Mr. McConnell for his service as director.

 

 
5

Table of Contents

 

Employment Agreements

 

Executive Employment Agreement – James Kras

 

On May 13, 2025, we entered into an amended and restated executive employment agreement with Mr. Kras (the “Employment Agreement”). Pursuant to the Employment Agreement, Mr. Kras will continue to serve as our Chief Executive Officer.

 

The Employment Agreement has a term of two years and automatically extends for additional one-year periods unless either party provides notice of non-renewal at least 90 days prior to the end of any term. Pursuant to the Employment Agreement, Mr. Kras is entitled to (i) an annual base salary of $450,000; (ii) an annual cash bonus with a target amount equal to 100% of his base salary based upon the determination of the compensation committee’s assessment of his performance and achieving our goals; (iii) equity awards under the 2025 Plan with an aggregate grant date value of at least $1,000,000; and (iv) participate in our benefit plans. Additionally, pursuant to the Employment Agreement, Mr. Kras received a transaction bonus of $500,000 following the completion of the transactions between us, Edible Garden Sustainable Ventures LLC, our wholly owned subsidiary, NaturalShrimp Farms Inc. and Streeterville Capital, LLC, as disclosed in our Current Report on Form 8-K, filed with the SEC on May 14, 2025. Pursuant to the Employment Agreement, on November 20, 2025, Mr. Kras received (i) an award of restricted stock units valued at $1,000,000, which will vest in four equal annual installments beginning on November 20, 2026; and (ii) an option award valued at $1,000,000, which will become exercisable in four equal annual installments beginning on November 20, 2026. The Employment Agreement contains standard restrictive covenants, including non-competition and non-solicitation, and terms and conditions customarily found in similar agreements.

 

Letter Agreement– Mathew McConnell

 

Pursuant to a letter agreement between us and Mr. McConnell, our Executive Vice President, he is entitled to an annual base salary of $275,000 and to participate in benefit plans and programs that are generally available to our employees. Mr. McConnell’s base salary may be reviewed annually by the compensation committee and adjusted based on individual performance, competitive market data, the scope of responsibilities, and our overall compensation philosophy.

 

Mr. McConnell’s employment under the letter agreement is at-will, which means that either Mr. McConnell or the Company can terminate his employment at any time.

 

Compensation Arrangements

 

Mr. Dafoulas, our interim Chief Financial Officer, is compensated based on an engagement letter by and between us and CapConnect dated as of November 6, 2023. Mr. Dafoulas is compensated for the services he provides at rates determined by us and CapConnect.

   

Potential Payments Upon Termination or Change in Control

 

Under the Employment Agreement, if Mr. Kras is terminated for cause, resigns without good reason, or his employment ends due to his death or permanent disability, he will be entitled to any earned but unpaid base salary plus accrued benefits earned through the date of termination.

 

Under the Employment Agreement, in the event of his termination without cause, he will receive (i) severance payments equal to 200% of his then-current base salary and 200% of the target performance bonus for the calendar year in which the termination occurs and (ii) an aggregate cash payment in an amount equal to his annual health insurance premium at the time of his termination multiplied by twelve. Further, if Mr. Kras is terminated without cause within six month prior to or twenty-four months following a Change of Control (as defined in the Employment Agreement), he will receive (i) severance payments equal to 300% of his then-current base salary and 300% of the target performance bonus for the calendar year in which the termination occurs; (ii) immediate vesting of his outstanding and unvested restricted stock, restricted stock units and stock options; and (iii) an aggregate cash payment in an amount equal to Mr. Kras’s annual health insurance premium at the time of his termination multiplied by thirty-six.

 

Mr. Kras is subject to non-competition and non-solicitation provisions under the Employment Agreement effective for the period of time equal to the greater of: (i) a period of two years following Mr. Kras’s termination of employment if he is still receiving certain severance payments from us; or (ii) a period of one year following Mr. Kras’s termination of employment. In all cases, Mr. Kras’s payments and benefits will be reduced, if necessary, to ensure that the payments and benefits to the executive will not be subject to the “golden parachute” excise tax imposed by Section 4999 of the Internal Revenue Code and the payments will be deductible by us.

 

 
6

Table of Contents

 

Outstanding Equity Awards at Fiscal Year-End

 

The following table sets forth the outstanding equity awards for our named executive officers as of December 31, 2025, all of which were issued pursuant to the 2025 Plan.

 

 

 

Option Awards

 

 

Stock Awards

 

 

 

 

 

 

Name

 

Equity Incentive Plan

Awards: Number of

Securities Underlying

Unexercised Unearned

Options (#)

 

 

Option

Exercise

Price

($)

 

 

Option

Expiration

Date

 

 

Equity Incentive

Plan Awards:

Number of

Unearned Shares,

Units or Other

Rights That Have

Not Vested

(#)

 

 

Equity Incentive

Plan Awards:

Market or Payout

Value of Unearned

Shares, Units, or

Other Rights That

Have Not Vested

($)

 

James E. Kras

 

 

98,825

(1) 

 

 

10.70

 

 

 11/20/2035

 

 

 

93,458

(2) 

 

 

1,000,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Kostas Dafoulas

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mathew McConnell 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)

These options were granted under the 2025 Plan and will vest in four equal annual installments commencing on November 20, 2026.

 

(2)

These restricted stock units, which convert into common stock on a one-for-one basis, were granted under the 2025 Plan and will vest in four equal annual installments commencing on November 20, 2026.

 

Equity Incentive Plan

 

Under the Company’s 2025 Plan we may issue up to 777,862 shares of common stock to employees, non-employee directors, and any other individuals who perform services for us. Under the 2025 Plan, we may issue awards including options, stock appreciation rights, restricted stock awards, restricted stock units, and other stock-based awards as the Board or compensation committee may determine.

 

Policies and Practices Related to the Grant of Certain Equity Awards

 

We have not adopted a formal policy governing the timing of equity awards, including stock options, in relation to the disclosure of material non-public information. The compensation committee does not grant equity awards in anticipation of the release of material non-public information. Similarly, we do not time the release of material nonpublic information based on equity award grant dates.

 

Director Compensation

 

In the year ended December 31, 2025, compensation for our non-employee directors included an annual cash retainer of up to $75,000. In addition, on November 20, 2025, Pamela DonAroma, Mathew McConnell, and Ryan Rogers received immediately vesting restricted stock awards under the 2025 Plan as compensation for their services as directors from 2023 through 2025. Further, on December 15, 2025, Ms. DonAroma received immediately vesting restricted stock awards to correct an administrative error in connection with the November 2025 grant.

 

 
7

Table of Contents

 

The following table sets forth information concerning non-employee director compensation during the year ended December 31, 2025. Refer to the “Summary Compensation Table” above for compensation earned by Messrs. Kras and McConnell in 2025.

 

Name

 

Fees earned or paid in cash($)

 

 

Stock

Awards ($)(1)

 

 

Total

($)

 

Ryan Rogers(2)

 

 

161,539

 

 

 

100,008

 

 

 

261,547

 

Pamela DonAroma(2)

 

 

161,539

 

 

 

124,167

 

 

 

285,711

 

Michael Naidrich(3)

 

 

-

 

 

 

131,810

 

 

 

131,810

 

 

 

(1)

Includes the aggregate grant date fair value of the RSAs granted during fiscal 2025 as computed in accordance with FASB ASC 718.

 

 

 

 

(2)

As of December 31, 2025, there were no unvested stock awards outstanding for Mr. Rogers or Ms. DonAroma.

 

 

 

 

(3)

As of December 31, 2025, Mr. Naidrich had unvested stock awards for an aggregate of 13,181 shares which will fully vest on December 29, 2026 subject to Mr. Naidrich’s continued service as a director.

Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

The information in this section is presented in accordance with the rules of the SEC. Under these rules, beneficial ownership of a class of capital stock includes (i) any shares over which the person, directly or indirectly, has or shares voting power or investment power, and (ii) any shares the person has the right to acquire within 60 days. If two or more persons share voting power or investment power with respect to specific securities, each person is deemed to be the beneficial owner of those securities. The calculations in this section are based on 5,213,691 shares of common stock and 11,103 shares of Series B Preferred Stock outstanding as of April 27, 2026.

 

 
8

Table of Contents

 

Beneficial Ownership of More Than 5% of the Company’s Shares

 

The table below presents certain information as of April 27, 2026 regarding the persons known to us to be the beneficial owner of more than 5% of the outstanding shares of our common stock.

 

Name and Address of Beneficial Owner

 

Number of Shares of Common Stock Beneficially Owned

 

 

Number of Shares of Series B Preferred Stock Beneficially Owned

 

 

Percent of Class Beneficially Owned

 

Streeterville Capital, LLC

297 Auto Mall Drive #4

St. George, Utah 84770

 

 

 

 

11,103

 

 

 

100%(1)

Armistice Capital, LLC

510 Madison Avenue, 7th Floor

New York, New York 10022

 

 

54,435

 

 

 

 

 

 

9.99%(2)

 

(1)

Under the terms of the Series B Preferred Stock, Streeterville Capital, LLC, as the holder of the Series B Preferred Stock, is entitled to vote upon all matters upon which holders of common stock have the right to vote. At the Annual Meeting, it is entitled to a number of votes equal to the lesser of 130,549 shares of common stock and 9.99% of our common stock, counted together with shares of our common stock. The Series B Preferred Stock is not convertible into shares of common stock.

(2)

This information is based on a Schedule 13G filed with the SEC on February 17, 2026 by Armistice Capital, LLC (“Armistice”) with respect to shares beneficially owned by it and certain of its subsidiaries. Armistice reports shared voting power with respect to 544,348 shares and shared dispositive power with respect to 544,348 shares as of December 31, 2025. We subsequently effected a 1-for-10 reverse stock split on February 3, 2026. The number of shares beneficially owned by Armistice listed above has been adjusted to account for the 1-for-10 reverse stock split.

 

Beneficial Ownership of Management and Directors

 

The table below presents certain information regarding the beneficial ownership of our common stock as of April 27, 2026 by:

 

·

each of our directors;

·

each of our named executive officers; and

·

all of our current directors and executive officers as a group.

 

Except as we otherwise indicate below and under applicable community property laws, we believe that the beneficial owners of the common stock listed below, based on information they have furnished to us, have sole voting and investment power with respect to the shares shown. Unless otherwise indicated, the address for each of the named beneficial owners is c/o Edible Garden AG Incorporated, 283 County Road 519, Belvidere, NJ 07823.

 

Name of Beneficial Owner

 

Shares Beneficially Owned

 

 

Percentage

 

Named Executive Officers

 

 

 

 

 

 

James E. Kras(1)

 

 

735

 

 

*

 

Kostas Dafoulas

 

 

 

 

 

 

Mathew McConnell(1)

 

 

9,355

 

 

*

 

Directors

 

 

 

 

 

 

 

 

Pamela DonAroma

 

 

11,162

 

 

*

 

Michael Naidrich(2)

 

 

13,181

 

 

*

 

Ryan Rogers

 

 

9,347

 

 

*

 

All directors and executive officers as a group (6 persons)

 

 

43,780

 

 

*

 

* Indicates less than 1%.

 

 

(1)

Messrs. Kras and McConnell are also directors of the Company.

 

(2)

 Includes 13,181 unvested shares of restricted stock that vest on December 29, 2026.

 

 
9

Table of Contents

 

Equity Compensation Plan Information

 

The following table shows the number of securities that may be issued pursuant to our equity compensation plans (including individual compensation arrangements) as of December 31, 2025:

 

Plan Category

 

Number of securities to be issued upon exercise of outstanding options,  warrants and rights

 

 

Weighted-average exercise price of outstanding options, warrants and rights

 

 

Number of securities remaining available for future issuance under equity compensation plans

 

Equity compensation plans approved by security holders(1)

 

 

98,825

 

 

$10.70(2)

 

 

831,270(3)

Equity compensation plans not approved by security holders

 

 

 

 

 

 

 

 

 

Total

 

 

98,825

 

 

$10.70

 

 

 

831,270

 

 

(1)

The 2022 Plan and the 2025 Plan contain evergreen provisions which allow for an increase in the number of shares available for issuance under the 2022 Plan and the 2025 Plan on the first day of each calendar year, in an amount equal to the lesser of 5% of the total number of shares outstanding on December 31 of the prior calendar year or such smaller number of shares as determined by the Board.

(2)

Restricted stock units do not have an exercise price and have been excluded from the calculation of weighted average exercise price.

(3)

Represents  777,862 and 53,408  shares of common stock remaining available for issuance under the 2025 Plan and 2022 Plan, respectively.

 

Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 

The following sets forth a summary of transactions since January 1, 2024, or any currently proposed transaction, in which the Company was to be a participant and the amount involved exceeded or exceeds $120,000 and in which any related person had or will have a direct or indirect material interest.

 

 
10

Table of Contents

 

Working Capital Funding from Executive Officers

 

From time to time, we enter into loans to purchase vehicles that are secured by the vehicle purchased. Some of these loans are also personally guaranteed by our chief executive officer and/or chief financial officer. These loans accrue interest at annual rates ranging from 7.64% to 18.66% and began maturing on dates beginning in April 2024 through February 2028.

  

Streeterville Capital, LLC and its Affiliates

 

Streeterville Capital, LLC ("Streeterville") is the sole holder of the Company's Series B Preferred Stock. Avondale Capital LLC ("Avondale") and Iowa Shrimp Holdings, LLC are affiliates of Streeterville. All three entities are considered related parties of the Company.

 

During the year ended December 31, 2025, the Company engaged in the following transactions with Streeterville and its affiliates:

 

 

·

Issued an aggregate of 15,500 shares of Series B Preferred Stock to Streeterville for total cash consideration of $3,500,000 and as non-cash consideration for the acquisition of the NaturalShrimp assets (see Note 4 under “Notes to Consolidated Financial Statements” included in the Original Form 10-K).

 

 

 

 

·

Settled accrued preferred return obligations through the issuance of 459 additional shares of Series B Preferred Stock with an aggregate stated value of $459,000.

 

 

 

 

·

Exchanged 175 shares of Series B Preferred Stock for shares of common stock during the year.

 

 

 

 

·

Entered into a secured promissory note with Avondale for gross proceeds of $1,750,000, of which $1,006,000 remained outstanding as of December 31, 2025, included in short-term debt on the consolidated balance sheet.

 

 

 

 

·

Entered into a below-market lease with Iowa Shrimp Holdings for the Iowa Facility at a base rent of $1.00 per month, the fair value of which was recorded as a favorable contract intangible of $3,532,749 at the acquisition date (see Notes 4 and 11 under “Notes to Consolidated Financial Statements” included in the Original Form 10-K).

 

 

 

 

·

Entered into a Note Purchase Agreement with Streeterville Capital, LLC for gross proceeds of $1,750,000, pursuant to which the Company issued to Streeterville a secured promissory note in the principal amount of $1,625,000, which included an original issue discount of $120,000 and reimbursement of Streeterville’s transaction expenses of $5,000, for a purchase price of $1,500,000.

 

The Streeterville Note bears interest at a rate of 8.0% per annum and matures 13 months after its issuance date. From time to time, beginning six months after issuance, Streeterville may redeem a portion of the Streeterville Note, not to exceed an amount of $50,000 per month. Subject to the terms and conditions set forth in the Streeterville Note, the Company may prepay all or any portion of the outstanding balance of the Streeterville Note at any time.

 

 
11

Table of Contents

 

Policies and Procedures for Transactions with Related Persons

 

We have adopted a written policy that our executive officers, directors, beneficial owners of more than 5% of any class of our capital stock, and any members of the immediate family of any of the foregoing persons (a “related party”) are not permitted to enter into a related party transaction with us without the prior consent of our audit committee. Any request for us to enter into a transaction with a related party in which the related party would have a direct or indirect interest must first be presented to our audit committee for review, consideration, and approval. In approving or rejecting any such proposal, our audit committee will consider the relevant facts and circumstances of the transaction available to it, including, but not limited to, whether the transaction is on terms no less favorable than terms generally available to an unrelated third party or to employees under the same or similar circumstances, and the extent of the related party’s interest in the transaction. The written policy requires that, in determining whether to approve or reject a related person transaction, our audit committee must consider, in light of known circumstances, whether the transaction is in or is not inconsistent with, our best interests and those of our stockholders, as our audit committee determines in good faith.

 

Director Independence

 

Our Board consists of James Kras, Pamela DonAroma, Mathew McConnell, Michael Naidrich and Ryan Rogers. Ms. DonAroma and Messrs. Naidrich and Rogers are considered independent based on the listing standards of Nasdaq. In order to promote open discussion among independent directors, our Board has a policy of regularly conducting executive sessions of independent directors at scheduled meetings led by the lead independent director and at other times requested by other independent directors. Executive sessions do not include directors who are not determined to be independent.

 

Item 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

 

Summary of Fees

 

The following table summarizes the aggregate fees billed for professional services rendered to us by Marcum LLP in the year ended December 31, 2024 and CBIZ CPAs in the year ended December 31, 2025.

 

 

 

(in thousands)

 

 

 

2025

 

 

2024

 

Audit Fees(1)

 

$317.2

 

 

$247.2

 

Audit-Related Fees(2)

 

 

 

 

 

 

Tax Fees(3)

 

 

 

 

 

 

All Other Fees(4)

 

 

134.7

 

 

 

159.7

 

Total Fees

 

$451.9

 

 

$406.9

 

(1)

“Audit Fees” are fees for professional services for the audit of our consolidated financial statements included in our Annual Report on Form 10-K and the review of financial statements included in the Company’s Quarterly Reports on Form 10-Q, or for services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements.

(2)

“Audit-Related Fees” are fees related to assurance and related services that are traditionally performed by an external auditor.

(3)

“Tax Fees” are fees related to tax advice and tax planning.

(4)

“All Other Fees” are billed for any services not included in the first three categories, including services such as reviewing our registration statements and providing related consents, and finance fees.

 

Pre-Approval Policy

 

The audit committee has adopted a policy to pre-approve all audit and permissible non-audit services. In its review of non-audit services, the audit committee considers whether the engagement could compromise the independence of our independent registered public accounting firm, whether the reasons of efficiency or convenience is in our best interest to engage our independent registered public accounting firm to perform the services, and whether the service may enhance our ability to manage or control risk or improve audit quality. Pre-approval is generally provided for up to one year, and any pre-approval is detailed as to the particular service or category of services and is generally subject to a specific budget. Our independent registered public accounting firm and management are required to periodically report to the audit committee regarding the extent of services provided by the independent registered public accounting firm in accordance with the pre-approval and the fees for the services performed to date.

 

 
12

Table of Contents

 

PART IV

 

Item 15. Exhibits and Financial Statement Schedules

 

(a) Financial Statements and Schedules

 

The financial statements and supplemental data are incorporated by reference from the Original Form 10-K, filed on March 31, 2026.

 

(b) Exhibits

 

The following exhibits are incorporated by reference and filed as part of this Annual Report on Form 10-K.

 

 

 

 

 

 

 

 

 

Incorporated by Reference

 

 

 

 

 

 

 

 

 

Exhibit

 

 

 

 

 

 

 

(Unless Otherwise Indicated)

Number

 

Exhibit Title

 

Form

 

File

 

Exhibit

 

Filing Date

 

 

 

 

 

 

 

 

 

 

 

3.1

 

Certificate of Incorporation.

 

Form S-1

 

333-260655

 

3.1

 

November 1, 2021

 

 

 

 

 

 

 

 

 

 

 

3.2

 

Certificate of Amendment to the Certificate of Incorporation filed September 8, 2021.

 

Form S-1

 

333-260655

 

3.2

 

November 1, 2021

 

 

 

 

 

 

 

 

 

 

 

3.3

 

Certificate of Amendment to the Certificate of Incorporation, filed May 3, 2022.

 

Form 10-Q

 

001-41371

 

3.1

 

June 21, 2022

 

 

 

 

 

 

 

 

 

 

 

3.4

 

Certificate of Amendment to the Certificate of Incorporation, filed January 24, 2023.

 

Form 8-K

 

001-41371

 

3.1

 

January 25, 2023

 

 

 

 

 

 

 

 

 

 

 

3.5

 

Certificate of Amendment to Certificate of Incorporation, filed June 8, 2023.

 

Form 8-K

 

001-41371

 

3.1

 

June 9, 2023

 

 

 

 

 

 

 

 

 

 

 

3.6

 

Certificate of Amendment to the Certificate of Incorporation, filed November 7, 2023.

 

Form 8-K

 

001-41371

 

3.1

 

November 9, 2023

 

 

 

 

 

 

 

 

 

 

 

3.7

 

Certificate of Amendment to the Certificate of Incorporation, filed April 1, 2024.

 

Form 8-K

 

001-41371

 

3.1

 

April 2, 2024

 

 

 

 

 

 

 

 

 

 

 

3.8

 

Certificate of Amendment to the Certificate of Incorporation, filed February 26, 2025.

 

Form 8-K

 

001-41371

 

3.1

 

February 27, 2025

 

 

 

 

 

 

 

 

 

 

 

3.9

 

Certificate of Amendment to the Certificate of Incorporation, filed January 29, 2026.

 

Form 8-K

 

001-41371

 

3.1

 

January 30, 2026

 

 

 

 

 

 

 

 

 

 

 

3.10

 

Amended and Restated Bylaws of Edible Garden AG Incorporated.

 

Form S-1/A

 

333-260655

 

3.4

 

December 21, 2021

 

 

 

 

 

 

 

 

 

 

 

3.11

 

Amendment No. 1 to the Amended and Restated Bylaws of Edible Garden AG Incorporated.

 

Form 8-K

 

001-41371

 

3.1

 

January 26, 2024

 
13

Table of Contents

 

3.12

 

Amended and Restated Certificate of Designation of Series B Preferred Stock, filed August 13, 2025.

 

Form 8-K

 

001-41371

 

3.1

 

August 14, 2025

 

 

 

 

 

 

 

 

 

 

 

4.1

 

Common Stock Purchase Warrant, dated October 7, 2021.

 

Form S-1

 

333-260655

 

10.17b

 

November 1, 2021

 

 

 

 

 

 

 

 

 

 

 

4.2

 

Form of Subsequent Evergreen Common Stock Purchase Warrant.

 

Form S-1/A

 

333-260655

 

10.17d

 

March 24, 2022

 

 

 

 

 

 

 

 

 

 

 

4.3

 

Form of Warrant dated May 9, 2022.

 

Form S-1

 

333-268800

 

4.1

 

December 15, 2022

 

 

 

 

 

 

 

 

 

 

 

4.4

 

Warrant Agency Agreement, dated as of May 9, 2022, between the Company and American Stock Transfer & Trust Company, LLC.

 

Form 8-K

 

001-41371

 

4.2

 

May 10, 2022

 

 

 

 

 

 

 

 

 

 

 

4.5

 

Form of Representative’s Warrant dated May 9, 2022.

 

Form 8-K

 

001-41371

 

4.1

 

May 10, 2022

 

 

 

 

 

 

 

 

 

 

 

4.6

 

Form of Warrant dated February 7, 2023.

 

Form 8-K

 

001-41371

 

4.1

 

February 8, 2023

 

 

 

 

 

 

 

 

 

 

 

4.7

 

Warrant Agency Agreement dated as of February 7, 2023 between the Company and American Stock Transfer & Trust Company, LLC.

 

Form 8-K

 

001-41371

 

4.3

 

February 8, 2023

 

 

 

 

 

 

 

 

 

 

 

4.8

 

Form of Representative’s Warrant dated February 7, 2023.

 

Form 8-K

 

001-41371

 

4.2

 

February 8, 2023

 

 

 

 

 

 

 

 

 

 

 

4.9

 

Form of Warrant dated September 8, 2023.

 

Form 8-K

 

001-41371

 

4.1

 

September 11, 2023

 

 

 

 

 

 

 

 

 

 

 

4.10

 

Form of Representative’s Warrant dated September 8, 2023.

 

Form 8-K

 

001-41371

 

4.2

 

September 11, 2023

 

 

 

 

 

 

 

 

 

 

 

4.11

 

Warrant Agency Agreement dated as of September 7, 2023 between the Company and Equiniti Trust Company, LLC.

 

Form 8-K

 

001-41371

 

4.3

 

September 11, 2023

 
14

Table of Contents

 

4.12

 

Form of Class A Warrant dated May 23, 2024.

 

Form 8-K

 

001-41371

 

4.1

 

May 29, 2024

 

 

 

 

 

 

 

 

 

 

 

4.13

 

Form of Class B Warrant dated May 23, 2024.

 

Form 8-K

 

001-41371

 

4.2

 

May 29, 2024

 

 

 

 

 

 

 

 

 

 

 

4.14

 

Form of Pre-Funded Warrant dated May 23, 2024.

 

Form 8-K

 

001-41371

 

4.3

 

May 29, 2024

 

 

 

 

 

 

 

 

 

 

 

4.15

 

Warrant Agency Agreement dated as of May 23, 2024 between the Company and Equiniti Trust Company, LLC.

 

Form 8-K

 

001-41371

 

4.4

 

May 29, 2024

 

 

 

 

 

 

 

 

 

 

 

4.16

 

Form of Placement Agent Warrant dated May 23, 2024.

 

Form 8-K

 

001-41371

 

4.5

 

May 29, 2024

 

 

 

 

 

 

 

 

 

 

 

4.17

 

Form of Class A Warrant dated September 30, 2024.

 

Form 8-K

 

001-41371

 

4.1

 

October 4, 2024

 

 

 

 

 

 

 

 

 

 

 

4.18

 

Form of Class B Warrant dated September 30, 2024.

 

Form 8-K

 

001-41371

 

4.2

 

October 4, 2024

 

 

 

 

 

 

 

 

 

 

 

4.19

 

Form of Pre-Funded Warrant dated September 30, 2024.

 

Form 8-K

 

001-41371

 

4.3

 

October 4, 2024

 

 

 

 

 

 

 

 

 

 

 

4.20

 

Warrant Agency Agreement dated as of September 30, 2024 between the Company and Equiniti Trust Company, LLC.

 

Form 8-K

 

001-41371

 

4.4

 

October 4, 2024

 

 

 

 

 

 

 

 

 

 

 

4.21

 

Form of Placement Agent Warrant dated September 30, 2024.

 

Form 8-K

 

001-41371

 

4.5

 

October 4, 2024

 

 

 

 

 

 

 

 

 

 

 

4.22

 

Description of Securities.

 

Form 10-K

 

001-41371

 

4.22

 

March 31, 2026

 

 

 

 

 

 

 

 

 

 

 

4.23

 

Form of Warrant dated October 16, 2025.

 

Form 8-K

 

001-41371

 

4.1

 

October 16, 2025

 

 

 

 

 

 

 

 

 

 

 

10.1+

 

Edible Garden AG Incorporated 2022 Equity Incentive Plan.

 

Form S-1/A

 

333-260655

 

10.22

 

January 19, 2022

 

 

 

 

 

 

 

 

 

 

 

10.2+

 

First Amendment to the Edible Garden AG Incorporated 2022 Equity Incentive Plan.

 

Form 8-K

 

001-41371

 

10.1

 

June 9, 2023

 

 

 

 

 

 

 

 

 

 

 

10.3+

 

Second Amendment to the Edible Garden AG Incorporated 2022 Equity Incentive Plan.

 

Form 8-K

 

001-41371

 

10.1

 

August 23, 2024

 

 

 

 

 

 

 

 

 

 

 

10.4

 

Edible Garden AG Incorporated Amended and Restated 2022 Equity Incentive Plan.

 

Form 8-K

 

001-41371

 

10.1

 

September 25, 2025

 

 

 

 

 

 

 

 

 

 

 

10.5+

 

Edible Garden AG Incorporated 2025 Officer and Director Equity Incentive Plan.

 

Form 8-K

 

001-41371

 

10.2

 

September 25, 2025

 

 

 

 

 

 

 

 

 

 

 

10.6+

 

Form of Employee Option Agreement under the Edible Garden AG Incorporated 2025 Officer and Director Equity Incentive Plan.

 

Form 10-K

 

001-41371

 

10.6

 

March 31, 2026

 

 

 

 

 

 

 

 

 

 

 

10.7+

 

Form of Employee RSU Agreement under the Edible Garden AG Incorporated 2025 Officer and Director Equity Incentive Plan.

 

Form 10-K

 

001-41371

 

10.7

 

March 31, 2026

 

 

 

 

 

 

 

 

 

 

 

10.8+

 

Form of Director RSA Agreement under the Edible Garden AG Incorporated 2025 Officer and Director Equity Incentive Plan.

 

Form 10-K

 

001-41371

 

10.8

 

March 31, 2026

 
15

Table of Contents

 

10.9+

 

Form of Director RSU Agreement for under the Edible Garden AG Incorporated 2025 Officer and Director Equity Incentive Plan.

 

Form 10-K

 

001-41371

 

10.9

 

March 31, 2026

 

 

 

 

 

 

 

 

 

 

 

10.10+

 

Amended and Restated Executive Employment Agreement, by and between Edible Garden AG Incorporated and James E. Kras, dated as of May 13, 2025.

 

Form 8-K

 

001-41371

 

10.5

 

May 14, 2025

 

 

 

 

 

 

 

 

 

 

 

10.11+

 

Form of Director Restricted Stock Award Agreement under the Edible Garden AG Incorporated 2022 Equity Incentive Plan.

 

Form 10-Q

 

001-41371

 

10.6

 

November 10, 2022

 

 

 

 

 

 

 

 

 

 

 

10.12+

 

Form of Indemnification Agreement.

 

Form 8-K

 

001-41371

 

10.1

 

January 26, 2024

 

 

 

 

 

 

 

 

 

 

 

10.13

 

Promissory Note, by and between 2900 Madison Ave Holdings, LLC and NJD Investments, LLC, dated as of August 31, 2022.

 

Form 8-K

 

001-41371

 

10.2

 

September 6, 2022

 

 

 

 

 

 

 

 

 

 

 

10.14

 

Mortgage, by and between 2900 Madison Ave Holdings, LLC and NJD Investments, LLC, dated as of August 30, 2022.

 

Form 8-K

 

001-41371

 

10.3 

 

September 6, 2022

 

 

 

 

 

 

 

 

 

 

 

10.15

 

Security Agreement, by and between 2900 Madison Ave Holdings, LLC and NJD Investments, LLC, dated as of August 30, 2022.

 

Form 8-K

 

001-41371

 

10.4

 

September 6, 2022

 

 

 

 

 

 

 

 

 

 

 

10.16

 

Guaranty, by Edible Garden AG Incorporated, dated as of August 30, 2022.

 

Form 8-K

 

001-41371

 

10.5

 

September 6, 2022

 

 

 

 

 

 

 

 

 

 

 

10.17±#

 

Purchase Agreement: Fresh Cut Herbs & Basil, dated as of January 1, 2024, by and between the Company and Meijer Distribution, Inc.

 

Form 8-K

 

001-41371

 

10.1

 

February 12, 2024

 

 

 

 

 

 

 

 

 

 

 

10.18±#

 

Purchase Agreement: Potted Herbs & Wheatgrass, dated as of January 1, 2024, by and between the Company and Meijer Distribution, Inc.

 

Form 8-K

 

001-41371

 

10.2

 

February 12, 2024

 

 

 

 

 

 

 

 

 

 

 

10.19±

 

Lease Agreement, made as of December 31, 2014, by and between Edible Garden Corp. and Whitetown Realty, LLC.

 

Form 8-K

 

001-41371

 

10.1

 

October 4, 2024

 

 

 

 

 

 

 

 

 

 

 

10.20±

 

Lease Extension Agreement, dated September 10, 2019, by and between Edible Garden Corp. and Whitetown Realty, LLC.

 

Form 8-K

 

001-41371

 

10.2

 

October 4, 2024

 

 

 

 

 

 

 

 

 

 

 

10.21

 

Equity Distribution Agreement, dated January 31, 2025, by and between Edible Garden AG Incorporated and Maxim Group LLC.

 

Form 8-K

 

001-41371

 

10.1

 

January 31, 2025

 

 

 

 

 

 

 

 

 

 

 

10.22

 

Standard Merchant Cash Advance Agreement, dated as of April 1, 2025, by and between the Company and Arin Funding LLC.

 

Form 8-K

 

001-41371

 

10.1

 

April 3, 2025

 
16

Table of Contents

 

10.23±

 

Asset Purchase Agreement, by and between NaturalShrimp Farms Inc., Streeterville Capital, LLC, Edible Garden Sustainable Ventures LLC and Edible Garden AG Incorporated, dated as of May 14, 2025.

 

Form 8-K

 

001-41371

 

10.1

 

May 14, 2025

 

 

 

 

 

 

 

 

 

 

 

10.24

 

Stock Purchase Agreement, by and between Edible Garden AG Incorporated and Streeterville Capital, LLC, dated as of May 14, 2025.

 

Form 8-K

 

001-41371

 

10.2

 

May 14, 2025

 

 

 

 

 

 

 

 

 

 

 

10.25

 

Lease Agreement, by and between Edible Garden Sustainable Ventures LLC and Iowa Shrimp Holdings, LLC, dated as of May 14, 2025.

 

Form 8-K

 

001-41371

 

10.3

 

May 14, 2025

 

 

 

 

 

 

 

 

 

 

 

10.26±

 

Note Purchase Agreement, by and between Edible Garden AG Incorporated and Avondale Capital, LLC, dated as of August 29, 2025.

 

Form 8-K

 

001-41371

 

10.1#

 

September 5, 2025

 

 

 

 

 

 

 

 

 

 

 

10.27

 

Secured Promissory Note, by and between Edible Garden AG Incorporated and Avondale Capital, LLC, effective as of August 29, 2025.

 

Form 8-K

 

001-41371

 

10.2

 

September 5, 2025

 

 

 

 

 

 

 

 

 

 

 

10.28

 

Security Agreement, by and between Edible Garden AG Incorporated and Avondale Capital, LLC, dated as of August 29, 2025.

 

Form 8-K

 

001-41371

 

10.3

 

September 5, 2025

 

 

 

 

 

 

 

 

 

 

 

10.29

 

Note Purchase Agreement, by and between the Company and Streeterville Capital, LLC, dated as of March 3, 2026.

 

Form 8-K

 

001-41371

 

10.1

 

March 4, 2026

 

 

 

 

 

 

 

 

 

 

 

10.30

 

Secured Promissory Note, dated as of March 3, 2026.

 

Form 8-K

 

001-41371

 

10.2

 

March 4, 2026

 

 

 

 

 

 

 

 

 

 

 

10.31

 

Security Agreement, by and between the Company and Streeterville Capital, LLC, dated as of March 3, 2026.

 

Form 8-K

 

001-41371

 

10.3

 

March 4, 2026

 

 

 

 

 

 

 

 

 

 

 

10.32

 

Guarantee, for the benefit of Streeterville Capital, LLC, dated as of March 3, 2026.

 

Form 8-K

 

001-41371

 

10.4

 

March 4, 2026

 

 

 

 

 

 

 

 

 

 

 

10.33#

 

Interim Order Agreement, by and between the Company and Tetra Pak Inc., dated as of March 4, 2026 for processing.

 

Form 8-K

 

001-41371

 

10.1

 

March 10, 2026

 

 

 

 

 

 

 

 

 

 

 

10.34#

 

Interim Order Agreement, by and between the Company and Tetra Pak Inc., dated as of March 4, 2026 for packaging.

 

Form 8-K

 

001-41371

 

10.2

 

March 10, 2026

 

 

 

 

 

 

 

 

 

 

 

10.35

 

Form of Inducement Letter Agreement dated May 21, 2025.

 

Form 10-Q

 

001-41371

 

10.7

 

August 14, 2025

 

 

 

 

 

 

 

 

 

 

 

10.36

 

Form of Inducement Letter Agreement dated October 16, 2025.

 

Form 8-K

 

001-41371

 

10.1

 

October 16, 2025

 

 

 

 

 

 

 

 

 

 

 

10.37+

 

Letter Agreement with Mathew McConnell

 

 

 

 

Filed herewith

 

 

 

 

 

 

 

 

 

 

 

16.1

 

Letter from Marcum LLP, dated April 23, 2025.

 

Form 8-K

 

001-41371

 

16.1

 

April 23, 2025

 

 

 

 

 

 

 

 

 

 

 

19.1

 

Edible Garden AG Incorporated Amended and Restated Insider Trading Policy.

 

Form 10-K

 

001-41371

 

19.1

 

March 31, 2025

 
17

Table of Contents

 

21.1

 

List of Subsidiaries.

 

Form 10-K

 

001-41371

 

21.1

 

March 31, 2026

 

 

 

 

 

 

 

 

 

 

 

23.1

 

Consent of CBIZ CPAs P.C., Independent Registered Public Accounting Firm.

 

Form 10-K

 

001-41371

 

23.1

 

March 31, 2026

 

 

 

 

 

 

 

 

 

 

 

23.2

 

Consent of Marcum LLP, Independent Registered Public Accounting Firm.

 

Form 10-K

 

001-41371

 

23.2

 

March 31, 2026

 

 

 

 

 

 

 

 

 

 

 

24.1

 

Power of Attorney.

 

Form 10-K

 

001-41371

 

24.1

 

March 31, 2026

 

 

 

 

 

 

 

 

 

 

 

31.1

 

Certification of the Principal Executive Officer.

 

__

 

__

 

__

 

Filed herewith

 

 

 

 

 

 

 

 

 

 

 

31.2

 

Certification of the Principal Financial Officer.

 

__

 

__

 

__

 

Filed herewith

 

 

 

 

 

 

 

 

 

 

 

32.1

 

Section 1350 Certifications.

 

Form 10-K

 

001-41371

 

32.1

 

March 31, 2026

 

 

 

 

 

 

 

 

 

 

 

97

 

Policy for the Recovery of Erroneously Awarded Compensation.

 

Form 10-K

 

001-41371

 

97

 

April 1, 2024

 

 

 

 

 

 

 

 

 

 

 

101.INS

 

Inline XBRL Instance Document.

 

Form 10-K

 

001-41371

 

101.INS

 

March 31, 2026

 

 

 

 

 

 

 

 

 

 

 

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document.

 

Form 10-K

 

001-41371

 

101.SCH

 

March 31, 2026

 

 

 

 

 

 

 

 

 

 

 

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

 

Form 10-K

 

001-41371

 

101.CAL

 

March 31, 2026

 

 

 

 

 

 

 

 

 

 

 

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document.

 

Form 10-K

 

001-41371

 

101.DEF

 

March 31, 2026

 

 

 

 

 

 

 

 

 

 

 

101.LAB

 

Inline XBRL Taxonomy Extension Label Linkbase Document.

 

Form 10-K

 

001-41371

 

101.LAB

 

March 31, 2026

 

 

 

 

 

 

 

 

 

 

 

101.PRE

 

The following financial statements from the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, formatted in Inline XBRL: (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Operations, (iii) Consolidated Statements of Stockholder’s Deficit, (iv) Consolidated Statements of Cash Flows, and (v) Notes to Consolidated Financial Statements, tagged as blocks of text and including detailed tags.

 

Form 10-K

 

001-41371

 

101.PRE

 

March 31, 2026

 

 

 

 

 

 

 

 

 

 

 

104

 

Cover Page Interactive Data File

 

___

 

__

 

__

 

Filed herewith

 

+

Management contract or compensatory arrangement.

±

Certain information has been omitted from this exhibit in reliance upon Item 601(a)(5) of Regulation S-K and will be furnished to the Securities and Exchange Commission upon request.

#

Certain portions of this exhibit have been omitted (indicated by asterisks) pursuant to Item 601(b) of Regulation S-K because the omitted information is (i) not material and (ii) the type of information that the Company treats as private or confidential.

 

 
18

Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. 

 

EDIBLE GARDEN AG INCORPORATED

 

 

 

 

Date: April 30, 2026

By:

/s/ James E. Kras

 

 

James E. Kras

 

 

Chief Executive Officer and President

(principal executive officer)

 

  

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated. 

 

Signature

 

Title

 

Date

 

 

 

 

 

/s/ James E. Kras

 

Chief Executive Officer, President and Director

 

April 30, 2026

James E. Kras

 

(principal executive officer)

 

 

 

 

 

 

 

*

 

Interim Chief Financial Officer

 

April 30, 2026

Kostas Dafoulas

 

(principal financial and accounting officer)

 

 

 

 

 

 

 

*

 

Director

 

April 30, 2026

Pamela DonAroma

 

 

 

 

 

 

 

 

 

*

 

Director

 

April 30, 2026

Mathew McConnell

 

 

 

 

 

 

 

 

 

*

 

Director

 

April 30, 2026

Michael Naidrich

 

 

 

 

 

 

 

 

 

*

 

Director

 

April 30, 2026

Ryan Rogers

 

 

 

 

 

 

 

 

 

*By:

/s/ James E. Kras

 

 

James E. Kras, as attorney-in-fact

 

 
19